Evaluating the Impact of Glucagon-Like Peptide-1 Receptor Agonists on Metabolic Changes in Patients With Type 2 Diabetes on High-Dose Insulin : American Journal of Therapeutics

Secondary Logo

Journal Logo

You can read the full text of this article if you:

Access through Ovid
Therapeutic Opinion

Evaluating the Impact of Glucagon-Like Peptide-1 Receptor Agonists on Metabolic Changes in Patients With Type 2 Diabetes on High-Dose Insulin

Rentsch, Tiffany PharmD1,2,*; Awad, Magdi PharmD, MSA1,2; Moorman, John M. PharmD, BCPS1; Gothard, Michael David MS, BS3

Author Information
doi: 10.1097/MJT.0000000000001283
  • Buy

Abstract

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.